Hengkang Medical Group Co Ltd
SZSE:002219
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (4), the stock would be worth ¥2.34 (0% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4 | ¥2.34 |
0%
|
| 3-Year Average | 4 | ¥2.34 |
+0%
|
| 5-Year Average | 5.1 | ¥2.99 |
+28%
|
| Industry Average | 2.3 | ¥1.32 |
-44%
|
| Country Average | 2.4 | ¥1.42 |
-39%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
7.9B CNY | 4 | 337.3 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
97.2B USD | -15.4 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 12.4 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.2B ZAR | 2.2 | 13.9 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.8B MYR | 2.6 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.5B ZAR | 1.5 | 4.5 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.8B BRL | 4.3 | 17.9 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.7B USD | 3.7 | 11.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
102.1B CNY | 4.6 | 30.3 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 12 | 60.5 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 4.8 | 31.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.4 |
| 70th Percentile | 3.9 |
| Max | 1 172 445.9 |
Other Multiples
Hengkang Medical Group Co Ltd
Glance View
Hengkang Medical Group Co Ltd. stands as a testament to the burgeoning evolution of healthcare in China. Founded with a vision to modernize traditional healthcare systems, the company has woven an intricate network of hospitals and healthcare services across the country, tapping into the ever-growing demand for quality medical care. At the heart of Hengkang's operations is its commitment to providing comprehensive medical services—from outpatient and inpatient care to specialized treatments—all under one roof. This vertically integrated approach not only ensures seamless delivery of care but also drives efficiencies through economies of scale. By investing in advanced medical technologies and skilled professionals, Hengkang positions itself as a leader in the healthcare landscape, providing services that cater to diverse medical needs, thereby consistently drawing a steady stream of patients and insurance collaborations. What sets Hengkang apart is its keen focus on aligning healthcare delivery with digital transformation. The company leverages digital platforms to streamline its operations, enhance patient experiences, and optimize resource allocation. This digital shift plays a crucial role in its revenue model—Hengkang taps into data analytics to provide value-added services, optimize operational workflows, and predict healthcare trends, which not only improve patient outcomes but also drive profitability. Furthermore, its portfolio extends beyond clinical care; the group actively engages in partnering with biotech research initiatives and health management programs, broadening its reach and reinforcing its market position as an integrated healthcare service provider. This multifaceted strategy ensures Hengkang's resilience and adaptability in an ever-changing industry, catalyzing its growth and solidifying its reputation as a beacon of modern healthcare.